SCHEMBL5114924

SCHEMBL5114924

CC(Oc1ccc(CC2c3ccc(O)cc3CCN2c2ccccc2C(F)(F)F)cc1)C1CCCCN1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.44
ESR2 Q92731 6/20 0.44
ADORA2A P29274 5/20 0.34
ADORA1 P30542 5/20 0.34
KCNH2 Q12809 4/20 0.34
CYP3A4 P08684 3/20 0.34
ADORA3 P0DMS8 2/20 0.34
ADORA2B P29275 1/20 0.34
CYP2C19 P33261 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
CNR1 P21554 1/20 0.34
GLRA1 P23415 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5115010 0.88 ESR1 (0.45) ESR1ESR2DRD2DRD1
SCHEMBL5101665 0.88 ESR1 (0.59) ESR1ESR2KDM4EDRD2DRD1
SCHEMBL5115645 0.87 ESR1 (0.46) ESR1ESR2KDM4EHTR2A
SCHEMBL5108948 0.85 ESR1 (0.48) ESR1ESR2
SCHEMBL5105659 0.85 ESR1 (0.48) ESR1ESR2KDM4EDRD2DRD1
SCHEMBL5115176 0.84 ESR1 (0.42) ESR1ESR2KDM4ESLC6A2HTR2A
SCHEMBL5104970 0.84 ESR1 (0.48) ESR1ESR2KCNH2CYP3A4CYP2C19
SCHEMBL5108305 0.84 ESR1 (0.48) ESR1ESR2KDM4ESLC6A2SLC6A4
SCHEMBL5115565 0.83 KDM4E (0.48) ESR1ESR2KCNH2KDM4EDRD2
SCHEMBL5104683 0.82 ESR1 (0.45) ESR1ESR2KDM4ESLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435729-B2 Compounds and methods for modulation of estrogen receptors SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-14 US disclosed
US-7279489-B2 Compounds and methods for modulation of estrogen receptors SIGNAL PHARMACEUTICALS, LLC (US) 2007-10-09 US disclosed
US-6593322-B1 Methods are disclosed for modulating ER- beta in cell and/or tissues expressing the same, including cells and/ or tissue that preferentially ER- beta . Methods for treating estrogen-related conditions are also disclosed, including SIGNAL PHARMACEUTICALS, INC. 2003-07-15 US disclosed
US-6436923-B1 ESTROGEN ANTAGONISTS AND/OR AGONISTS FOR TREATING ESTROGEN-RELATED CONDITIONS SIGNAL PHARMACEUTICALS, INC. 2002-08-20 US disclosed